Darwin Global Management »

Keros Therapeutics shares owned by Darwin Global Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Darwin Global Management from 13F filings

Historical chart of Darwin Global Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Darwin Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Darwin Global Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $42M 1.1M 39.76
2023-03-31 $1.3M 31k 42.70
2022-12-31 $21M 429k 48.02
2021-12-31 $6.5M 112k 58.51
2021-06-30 $4.4M 104k 42.47
2021-03-31 $5.3M 87k 61.55